Fujian Wanchen Biotechnology Co. Ltd (300972) — Cash Flow Quality Index
Fujian Wanchen Biotechnology Co. Ltd (300972) has a Cash Flow Quality Index of 2.70x as of December 2025. Operating cash flow of CN¥3.63 Billion exceeds net income of CN¥1.34 Billion, indicating high earnings quality where cash backs reported profits. Also explore Fujian Wanchen Biotechnology Co. Ltd balance sheet assets for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Fujian Wanchen Biotechnology Co. Ltd Cash Flow Quality Index (2019–2025)
Historical Cash Flow Quality Index for Fujian Wanchen Biotechnology Co. Ltd across 6 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check how tangible is Fujian Wanchen Biotechnology Co. Ltd's equity to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Fujian Wanchen Biotechnology Co. Ltd (2019–2025)
Year-by-year earnings quality comparison for Fujian Wanchen Biotechnology Co. Ltd. For live market cap and the full company financial profile, see 300972 company net worth.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 2.70x | CN¥3.63 Billion | CN¥1.34 Billion | ▼ -6.6% |
| 2024 | 2.89x | CN¥848.35 Million | CN¥293.52 Million | ▲ +96.1% |
| 2022 | 1.47x | CN¥70.38 Million | CN¥47.77 Million | ▼ -63.8% |
| 2021 | 4.07x | CN¥98.82 Million | CN¥24.28 Million | ▲ +150.4% |
| 2020 | 1.63x | CN¥156.24 Million | CN¥96.13 Million | ▼ -15.5% |
| 2019 | 1.92x | CN¥177.28 Million | CN¥92.19 Million | — |